Selective Targeting of Gain-of-Function KCNQ1 Mutations Predisposing to Atrial Fibrillation

被引:24
|
作者
Campbell, Courtney M. [1 ]
Campbell, Jonathan D. [3 ]
Thompson, Christopher H. [2 ]
Galimberti, Eleonora Savio [2 ]
Darbar, Dawood [1 ,2 ]
Vanoye, Carlos G. [2 ]
George, Alfred L., Jr. [1 ,2 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
[3] So Methodist Univ, Dept Engn Management Informat & Syst, Dallas, TX 75275 USA
来源
关键词
antiarrhythmic drugs; arrhythmias; cardiac; atrial fibrillation; genetics; potassium channels; RECTIFIER POTASSIUM CHANNEL; TORSADES-DE-POINTES; I-KS; NATURAL-HISTORY; CAUSE JERVELL; K+ CURRENT; SLOW; BLOCKER; RISK; REPOLARIZATION;
D O I
10.1161/CIRCEP.113.000439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Atrial fibrillation is the most common sustained cardiac arrhythmia in adults. We hypothesized that gain-of-function KCNQ1 mutations previously associated with familial atrial fibrillation have distinct pharmacological properties that may enable targeted inhibition. Methods and Results Wild-type (WT) KCNQ1 or the familial atrial fibrillation mutation KCNQ1-S140G was heterologously coexpressed with KCNE1 to enable electrophysiological recording of the slow delayed rectifier current (I-Ks) and investigation of pharmacological effects of the I-Ks selective blocker HMR-1556. Coexpression of KCNQ1-S140G with KCNE1 generated potassium currents (S140G-I-Ks) that exhibited greater sensitivity to HMR-1556 than WT-I-Ks. Enhanced HMR-1556 sensitivity was also observed for another gain-of-function atrial fibrillation mutation, KCNQ1-V141M. Heteromeric expression of KCNE1 with both KCNQ1-WT and KCNQ1-S140G generated currents (HET-I-Ks) with gain-of-function features, including larger amplitude, a constitutively active component, hyperpolarized voltage dependence of activation, and extremely slow deactivation. A low concentration of HMR-1556, which had little effect on WT-I-Ks but was capable of inhibiting the mutant channel, reduced both instantaneous and steady state HET-I-Ks to levels that were not significantly different from WT-I-Ks and attenuated use-dependent accumulation of the current. In cultured adult rabbit left atrial myocytes, expression of S140G-I-Ks shortened action potential duration compared with WT-I-Ks. Application of HMR-1556 mitigated S140G-I-Ks-induced action potential duration shortening and did not alter action potential duration in cells expressing WT-I-Ks. Conclusions The enhanced sensitivity of KCNQ1 gain-of-function mutations for HMR-1556 suggests the possibility of selective therapeutic targeting, and, therefore, our data illustrate a potential proof of principle for genotype-specific treatment of this heritable arrhythmia.
引用
收藏
页码:960 / 966
页数:7
相关论文
共 50 条
  • [1] KCNQ1 gain-of-function mutation in familial atrial fibrillation
    Chen, YH
    Xu, SJ
    Bendahhou, S
    Wang, XL
    Wang, Y
    Xu, WY
    Jin, HW
    Sun, H
    Su, XY
    Zhuang, QN
    Yang, YQ
    Li, YB
    Liu, Y
    Xu, HJ
    Li, XF
    Ma, N
    Mou, CP
    Chen, Z
    Barhanin, J
    Huang, W
    [J]. SCIENCE, 2003, 299 (5604) : 251 - 254
  • [2] KCNQ1 gain-of-function mutation associated with familial atrial fibrillation
    Darbar, Dawood
    Abraham, Robert
    Kucera, Gayle
    Stubblefield, Tanya
    Yang, Tao
    Roden, Dan M.
    [J]. CIRCULATION, 2007, 116 (16) : 652 - 652
  • [3] Interaction Between KCNQ1 Gain-of-Function Residues
    Vanoye, Carlos G.
    Welch, Richard C.
    Kroncke, Brett M.
    George, Alfred L.
    Sanders, Charles R.
    [J]. BIOPHYSICAL JOURNAL, 2014, 106 (02) : 141A - 141A
  • [4] Mutations in KCNQ1 are an uncommon cause of atrial fibrillation
    Ellinor, PT
    Moore, RK
    Patton, KK
    Ruskin, JN
    MacRae, CA
    [J]. CIRCULATION, 2003, 108 (17) : 182 - 183
  • [5] KCNQ1 and KCNE3 mutations associated with atrial fibrillation
    Rhodes, Troy E.
    Manderfield, Lauren J.
    Lundquist, Andrew L.
    George, Alfred L., Jr.
    Donahue, Brian S.
    Roden, Dan M.
    Darbar, Dawood
    [J]. CIRCULATION, 2006, 114 (18) : 59 - 60
  • [6] Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation
    Ellinor, PT
    Moore, RK
    Patton, KK
    Ruskin, JN
    Pollak, MR
    MacRae, CA
    [J]. HEART, 2004, 90 (12) : 1487 - 1488
  • [7] Gain-of-function mutations in GATA6 lead to atrial fibrillation
    Tucker, Nathan R.
    Mahida, Saagar
    Ye, Jiangchuan
    Abraham, Elizabeth J.
    Mina, Julie A.
    Parsons, Victoria A.
    McLellan, Michael A.
    Shea, Marisa A.
    Hanley, Alan
    Benjamin, Emelia J.
    Milan, David J.
    Lin, Honghuang
    Ellinor, Patrick T.
    [J]. HEART RHYTHM, 2017, 14 (02) : 284 - 291
  • [8] Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations
    Peng, Gary
    Barro-Soria, Rene
    Sampson, Kevin J.
    Larsson, H. Peter
    Kass, Robert S.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations
    Gary Peng
    Rene Barro-Soria
    Kevin J. Sampson
    H. Peter Larsson
    Robert S. Kass
    [J]. Scientific Reports, 7
  • [10] Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1
    Chan, Priscilla J.
    Osteen, Jeremiah D.
    Xiong, Dazhi
    Bohnen, Michael S.
    Doshi, Darshan
    Sampson, Kevin J.
    Marx, Steven O.
    Karlin, Arthur
    Kass, Robert S.
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2012, 139 (02): : 135 - 144